Biocon Biologics gets Rs 1,125 cr capital infusion from Goldman Sachs

New Delhi, Nov 7 () Biocon on Saturday said its subsidiary Biocon Biologics has approved a Rs 1,125 crore investment from Goldman Sachs.New Delhi, Nov 7 () Biocon on Saturday said its subsidiary Biocon Biologics has approved a Rs 1,125 crore investment from Goldman Sachs.Read More

Leave a Reply

Your email address will not be published.